OptiNose, Inc.·4

Dec 13, 3:58 PM ET

Bednarski Eric 4

4 · OptiNose, Inc. · Filed Dec 13, 2021

Insider Transaction Report

Form 4
Period: 2021-12-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-10+28,87928,879 total
    Exercise: $1.63Exp: 2031-12-10Common Stock (28,879 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable over a three-year period commencing on December 10, 2021. Thirty-three percent (33%) of the option vests and becomes exercisable on December 10, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer.

Documents

1 file
  • 4
    wf-form4_163942906877243.xmlPrimary

    FORM 4